Clinical Trials Browser

OTHER × Psoriasis × Adalimumab × Clear all

NCT00932113 2017-08-31

MOA

Phase 4 Completed

33 enrolled 11 charts

Psoriasis

NCT02376478 2015-03-03

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Psoriasis, Inflammatory Bowel Diseases